BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22217448)

  • 21. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
    Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.
    Malik AK; Baldwin ME; Peale F; Fuh G; Liang WC; Lowman H; Meng G; Ferrara N; Gerber HP
    Blood; 2006 Jan; 107(2):550-7. PubMed ID: 16189273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of mesenchymal stem cells with fibroblast-like synoviocytes via cadherin-11 promotes angiogenesis by enhanced secretion of placental growth factor.
    Park SJ; Kim KJ; Kim WU; Cho CS
    J Immunol; 2014 Apr; 192(7):3003-10. PubMed ID: 24574497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.
    Rakic JM; Lambert V; Devy L; Luttun A; Carmeliet P; Claes C; Nguyen L; Foidart JM; Noël A; Munaut C
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3186-93. PubMed ID: 12824270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
    Luttun A; Tjwa M; Moons L; Wu Y; Angelillo-Scherrer A; Liao F; Nagy JA; Hooper A; Priller J; De Klerck B; Compernolle V; Daci E; Bohlen P; Dewerchin M; Herbert JM; Fava R; Matthys P; Carmeliet G; Collen D; Dvorak HF; Hicklin DJ; Carmeliet P
    Nat Med; 2002 Aug; 8(8):831-40. PubMed ID: 12091877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placental growth factor upregulation is a host response to antiangiogenic therapy.
    Bagley RG; Ren Y; Weber W; Yao M; Kurtzberg L; Pinckney J; Bangari D; Nguyen C; Brondyk W; Kaplan J; Teicher BA
    Clin Cancer Res; 2011 Mar; 17(5):976-88. PubMed ID: 21343374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.
    Schomber T; Kopfstein L; Djonov V; Albrecht I; Baeriswyl V; Strittmatter K; Christofori G
    Cancer Res; 2007 Nov; 67(22):10840-8. PubMed ID: 18006829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placenta growth factor is a survival factor for human malignant mesothelioma cells.
    Albonici L; Doldo E; Palumbo C; Orlandi A; Bei R; Pompeo E; Mineo TC; Modesti A; Manzari V
    Int J Immunopathol Pharmacol; 2009; 22(2):389-401. PubMed ID: 19505392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor angiogenesis and anti-angiogenic therapies.
    Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
    Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is PlGF a plaque growth factor?
    Sainz J; Sata M
    Cardiovasc Res; 2010 Apr; 86(1):4-5. PubMed ID: 20123695
    [No Abstract]   [Full Text] [Related]  

  • 31. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
    Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
    Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer.
    Chen CN; Hsieh FJ; Cheng YM; Cheng WF; Su YN; Chang KJ; Lee PH
    Cancer Lett; 2004 Sep; 213(1):73-82. PubMed ID: 15312686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical role of placental growth factor in the induction of inflammation and edema formation.
    Oura H; Bertoncini J; Velasco P; Brown LF; Carmeliet P; Detmar M
    Blood; 2003 Jan; 101(2):560-7. PubMed ID: 12393422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of PLGF production by 15-(S)-HETE via PI3K-Akt, NF-κB and COX-2 pathways in rheumatoid arthritis synovial fibroblast.
    Wu MY; Yang RS; Lin TH; Tang CH; Chiu YC; Liou HC; Fu WM
    Eur J Pharmacol; 2013 Aug; 714(1-3):388-96. PubMed ID: 23872401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human choriocarcinomas: placental growth factor-dependent preclinical tumor models.
    Bagley RG; Ren Y; Kurtzberg L; Weber W; Bangari D; Brondyk W; Teicher BA
    Int J Oncol; 2012 Feb; 40(2):479-86. PubMed ID: 22075622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
    Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
    J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptor-1 predicts the prognosis of hepatocellular carcinoma.
    Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Hisamoto T; Yoshida Y; Abe M; Koga H; Toirimura T; Ueno T; Sata M
    Oncol Rep; 2010 Jun; 23(6):1647-54. PubMed ID: 20428821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders.
    Luttun A; Tjwa M; Carmeliet P
    Ann N Y Acad Sci; 2002 Dec; 979():80-93. PubMed ID: 12543719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.
    Schultze A; Ben Batalla I; Riethdorf S; Bubenheim M; Yekebas E; Erbersdobler A; Reichelt U; Effenberger KE; Schmidt T; Izbicki JR; Bokemeyer C; Pantel K; Fiedler W; Loges S
    Clin Exp Metastasis; 2012 Dec; 29(8):879-87. PubMed ID: 22484977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
    Zins K; Kovatchki D; Lucas T; Abraham D
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.